Patent ID: 7709460

Claim:
A method for treating an individual having a disease selected from the group consisting of Alzheimer's disease, age-related cognitive decline, mild cognitive impairment, senile dementia, chronic fatigue syndrome, multiple sclerosis, vascular dementia, depression, and vascular disease; wherein the disease has symptoms associated with a functional Vitamin B 12 deficiency; said method comprising administering to the individual a therapeutically effective amount of a composition or compositions that comprise: (i) a first component selected from the group consisting of Vitamin B 12 (cyanocobalamin), hydroxycobalamin, and methylcobalamin; and (ii) a second component which is N-acetyl cysteine; wherein the first and second components may be administered concurrently or separately; Wherein: the individual's intracellular processing of cobalamin increases after administering the composition or compositions, and the symptoms associated with the functional Vitamin B 12 deficiency improve.